ADCT-242

N/A

Report date: 2026/03/10 20:00:16

Base Information

Drug NameADCT-242
Drug Alias NameADCT-242ADCT242
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CLDN6DNA topoisomerase I inhibitors
TargetsClaudin 6DNA topoisomerase I
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdc Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesAdc Therapeutics Sa
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A